Girisopam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401530This classification denotes an anxiolytic with the molecular formula C18H17ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2LP301A921, chemically known as 5h-2,3-benzodiazepine, 1-(3-chlorophenyl)-7,8-dimethoxy-4-methyl- but generally known as girisopam, which bears US NIH Compound Identifier 71257. European Medicines Agency schedules Girisopam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07907MIG. The term GIRISOPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). GIRISOPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule girisopam under HS 29339940 and SITC 51577. As of Q4 2014, GIRISOPAM remains the US FDA Preferred Term for this commodity. Girisopam bears US NLM identifiers UMLS ID C0164299 and NCI Concept Code C74182. SMILES: CLC1CC(C2=NN=C(CC3C2CC(OC)C(OC)C3)C)CCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.